Terabe M - Search Results

1

Pathogenic roles of CD14, galectin-3, and OX40 during experimental cerebral malaria in mice.

Oakley MS, Majam V, Mahajan B, Gerald N, Anantharaman V, Ward JM, Faucette LJ, McCutchan TF, Zheng H, Terabe M, Berzofsky JA, Aravind L, Kumar S. Oakley MS, et al. Among authors: terabe m. PLoS One. 2009 Aug 27;4(8):e6793. doi: 10.1371/journal.pone.0006793. PLoS One. 2009. PMID: 19710907 Free PMC article.

2

Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

Kawakami K, Terabe M, Kawakami M, Berzofsky JA, Puri RK. Kawakami K, et al. Among authors: terabe m. Cancer Res. 2006 Apr 15;66(8):4434-42. doi: 10.1158/0008-5472.CAN-05-1265. Cancer Res. 2006. PMID: 16618770

3

The contrasting roles of NKT cells in tumor immunity.

Berzofsky JA, Terabe M. Berzofsky JA, et al. Among authors: terabe m. Curr Mol Med. 2009 Aug;9(6):667-72. doi: 10.2174/156652409788970706. Curr Mol Med. 2009. PMID: 19689293 Free PMC article. Review.

4

Role of IL-13 in regulation of anti-tumor immunity and tumor growth.

Terabe M, Park JM, Berzofsky JA. Terabe M, et al. Cancer Immunol Immunother. 2004 Feb;53(2):79-85. doi: 10.1007/s00262-003-0445-0. Epub 2003 Nov 11. Cancer Immunol Immunother. 2004. PMID: 14610620 Free PMC article. Review.

5

Tissue-Specific Roles of NKT Cells in Tumor Immunity.

Terabe M, Berzofsky JA. Terabe M, et al. Front Immunol. 2018 Aug 15;9:1838. doi: 10.3389/fimmu.2018.01838. eCollection 2018. Front Immunol. 2018. PMID: 30158927 Free PMC article. Review.

6

Immunoregulatory T cells in tumor immunity.

Terabe M, Berzofsky JA. Terabe M, et al. Curr Opin Immunol. 2004 Apr;16(2):157-62. doi: 10.1016/j.coi.2004.01.010. Curr Opin Immunol. 2004. PMID: 15023407 Review.

7

Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors.

Kawakami K, Terabe M, Kioi M, Berzofsky JA, Puri RK. Kawakami K, et al. Among authors: terabe m. Clin Cancer Res. 2006 Aug 1;12(15):4678-86. doi: 10.1158/1078-0432.CCR-06-0192. Clin Cancer Res. 2006. PMID: 16899618

8

NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis.

Berzofsky JA, Terabe M. Berzofsky JA, et al. Among authors: terabe m. J Immunol. 2008 Mar 15;180(6):3627-35. doi: 10.4049/jimmunol.180.6.3627. J Immunol. 2008. PMID: 18322166 Review.

9

A novel immunoregulatory axis of NKT cell subsets regulating tumor immunity.

Berzofsky JA, Terabe M. Berzofsky JA, et al. Among authors: terabe m. Cancer Immunol Immunother. 2008 Nov;57(11):1679-83. doi: 10.1007/s00262-008-0495-4. Epub 2008 Mar 28. Cancer Immunol Immunother. 2008. PMID: 18369622 Free PMC article.

10

A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models.

Nakashima H, Terabe M, Berzofsky JA, Husain SR, Puri RK. Nakashima H, et al. Among authors: terabe m. J Immunol. 2011 Nov 15;187(10):4935-46. doi: 10.4049/jimmunol.1102095. Epub 2011 Oct 17. J Immunol. 2011. PMID: 22013118 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page